These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37953355)

  • 61. Comparison of the spectra of genetic damage in N4-hydroxycytidine-induced ad-3 mutations between nucleotide excision repair-proficient and -deficient heterokaryons of Neurospora crassa.
    de Serres FJ; Brockman HE
    Mutat Res; 1993 Feb; 285(2):145-63. PubMed ID: 7678887
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synthesis and anti-SARS-CoV-2 evaluation of lipid prodrugs of β-D-N
    Wen ZH; Wang MM; Li LY; Herdewijn P; Snoeck R; Andrei G; Liu ZP; Liu C
    Bioorg Chem; 2023 Jun; 135():106527. PubMed ID: 37031504
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A path from synthesis to emergency use authorization of molnupiravir as a COVID-19 therapy.
    Sakander N; Ahmed A; Bhardwaj M; Kumari D; Nandi U; Mukherjee D
    Bioorg Chem; 2024 Jun; 147():107379. PubMed ID: 38643567
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mutagenic nucleoside analog N4-aminocytidine: metabolism, incorporation into DNA, and mutagenesis in Escherichia coli.
    Negishi K; Tamanoi K; Ishii M; Kawakami M; Yamashita Y; Hayatsu H
    J Bacteriol; 1988 Nov; 170(11):5257-62. PubMed ID: 3053653
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A single amino acid limits the substrate specificity of Thermus thermophilus uridine-cytidine kinase to cytidine.
    Tomoike F; Nakagawa N; Kuramitsu S; Masui R
    Biochemistry; 2011 May; 50(21):4597-607. PubMed ID: 21539325
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Synthesis and biologic study of IV-14, a new ribonucleoside radiotracer for tumor visualization.
    Zlatopolskiy BD; Morgenroth A; Kunkel FH; Urusova EA; Dinger C; Kull T; Lepping C; Reske SN
    J Nucl Med; 2009 Nov; 50(11):1895-903. PubMed ID: 19837748
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mutagenic action of N4-hydroxycytidine on Escherichia coli B cyt-.
    Salganik RI; Vasjunina EA; Poslovina AS; Andreeva IS
    Mutat Res; 1973 Oct; 20(1):1-5. PubMed ID: 4586551
    [No Abstract]   [Full Text] [Related]  

  • 68. Synthesis and antiviral evaluation of a mutagenic and non-hydrogen bonding ribonucleoside analogue: 1-beta-D-Ribofuranosyl-3-nitropyrrole.
    Harki DA; Graci JD; Korneeva VS; Ghosh SK; Hong Z; Cameron CE; Peterson BR
    Biochemistry; 2002 Jul; 41(29):9026-33. PubMed ID: 12119016
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Molnupiravir and Its Active Form, EIDD-1931, Show Potent Antiviral Activity against Enterovirus Infections In Vitro and In Vivo.
    Li Y; Liu M; Yan Y; Wang Z; Dai Q; Yang X; Guo X; Li W; Chen X; Cao R; Zhong W
    Viruses; 2022 May; 14(6):. PubMed ID: 35746614
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Structural and Biochemical Studies on the Reaction Mechanism of Uridine-Cytidine Kinase.
    Tomoike F; Nakagawa N; Kuramitsu S; Masui R
    Protein J; 2015 Dec; 34(6):411-20. PubMed ID: 26510656
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inhibitors of dihydroorotate dehydrogenase cooperate with molnupiravir and N4-hydroxycytidine to suppress SARS-CoV-2 replication.
    Stegmann KM; Dickmanns A; Heinen N; Blaurock C; Karrasch T; Breithaupt A; Klopfleisch R; Uhlig N; Eberlein V; Issmail L; Herrmann ST; Schreieck A; Peelen E; Kohlhof H; Sadeghi B; Riek A; Speakman JR; Groß U; Görlich D; Vitt D; Müller T; Grunwald T; Pfaender S; Balkema-Buschmann A; Dobbelstein M
    iScience; 2022 May; 25(5):104293. PubMed ID: 35492218
    [TBL] [Abstract][Full Text] [Related]  

  • 72. N4-aminocytidine, a nucleoside analog that has an exceptionally high mutagenic activity.
    Negishi K; Harada C; Ohara Y; Oohara K; Nitta N; Hayatsu H
    Nucleic Acids Res; 1983 Aug; 11(15):5223-33. PubMed ID: 6224136
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mechanisms of resistance to azacitidine in human leukemia cell lines.
    Sripayap P; Nagai T; Uesawa M; Kobayashi H; Tsukahara T; Ohmine K; Muroi K; Ozawa K
    Exp Hematol; 2014 Apr; 42(4):294-306.e2. PubMed ID: 24368162
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Population pharmacokinetics of molnupiravir in adults with COVID-19: Lack of clinically important exposure variation across individuals.
    Bihorel S; Cao Y; Chawla A; Birger R; Maas BM; Gao W; Roepcke S; Sardella S; Humphrey R; Kondragunta S; Jayaraman B; Martinho M; Painter W; Painter G; Holman W; De Anda C; Brown ML; Johnson MG; Paschke A; Rizk ML; Stone JA
    CPT Pharmacometrics Syst Pharmacol; 2023 Dec; 12(12):1859-1871. PubMed ID: 37798914
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Spectrum of N4-aminocytidine mutagenesis.
    Bessho T; Matsumoto K; Nomura A; Hayatsu H; Negishi K
    J Mol Biol; 1989 Feb; 205(4):659-64. PubMed ID: 2648011
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of proofreading and dam-instructed mismatch repair systems on N4-hydroxycytidine-induced mutagenesis.
    Sledziewska-Gójska E; Janion C
    Mol Gen Genet; 1982; 186(3):411-8. PubMed ID: 6750321
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Metabolic and Non-Metabolic Roles of UCK2 in Tumor Progression.
    Fu Y; Wei XD; Guo L; Wu K; Le J; Ma Y; Kong X; Tong Y; Wu H
    Front Oncol; 2022; 12():904887. PubMed ID: 35669416
    [TBL] [Abstract][Full Text] [Related]  

  • 78. SARS-CoV-2 RdRp uses NDPs as a substrate and is able to incorporate NHC into RNA from diphosphate form molnupiravir.
    Wang M; Wu C; Liu N; Zhang F; Dong H; Wang S; Chen M; Jiang X; Zhang K; Gu L
    Int J Biol Macromol; 2023 Jan; 226():946-955. PubMed ID: 36528144
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
    Katahira R; Ashihara H
    Planta; 2002 Sep; 215(5):821-8. PubMed ID: 12244448
    [TBL] [Abstract][Full Text] [Related]  

  • 80. N4-hydroxycytidine, the active compound of Molnupiravir, promotes SARS-CoV-2 mutagenesis and escape from a neutralizing nanobody.
    Zibat A; Zhang X; Dickmanns A; Stegmann KM; Dobbelstein AW; Alachram H; Soliwoda R; Salinas G; Groß U; Görlich D; Kschischo M; Wollnik B; Dobbelstein M
    iScience; 2023 Oct; 26(10):107786. PubMed ID: 37731621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.